(1)
Integrated Computational Design, Green Synthesis, and Characterization of 3,4-Dihydropyrimidine Derivatives Targeting Enoyl-Acyl Carrier Protein Reductase for Tuberculosis Treatment. Int. J. Res. Pharm. Sci. Technol. 2026, 9 (3). https://doi.org/10.33974/bnb32f45.